Cargando…

Dabigatran level monitoring prior to idarucizumab administration in patients requiring emergent cardiac surgery

Detalles Bibliográficos
Autores principales: Litwinowicz, Radoslaw, Konstanty-Kalandyk, Janusz, Goralczyk, Tadeusz, Bartus, Krzysztof, Mazur, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756273/
https://www.ncbi.nlm.nih.gov/pubmed/29222699
http://dx.doi.org/10.1007/s11239-017-1587-9
_version_ 1783290693686394880
author Litwinowicz, Radoslaw
Konstanty-Kalandyk, Janusz
Goralczyk, Tadeusz
Bartus, Krzysztof
Mazur, Piotr
author_facet Litwinowicz, Radoslaw
Konstanty-Kalandyk, Janusz
Goralczyk, Tadeusz
Bartus, Krzysztof
Mazur, Piotr
author_sort Litwinowicz, Radoslaw
collection PubMed
description
format Online
Article
Text
id pubmed-5756273
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-57562732018-01-22 Dabigatran level monitoring prior to idarucizumab administration in patients requiring emergent cardiac surgery Litwinowicz, Radoslaw Konstanty-Kalandyk, Janusz Goralczyk, Tadeusz Bartus, Krzysztof Mazur, Piotr J Thromb Thrombolysis Letter to the Editor Springer US 2017-12-08 2018 /pmc/articles/PMC5756273/ /pubmed/29222699 http://dx.doi.org/10.1007/s11239-017-1587-9 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Letter to the Editor
Litwinowicz, Radoslaw
Konstanty-Kalandyk, Janusz
Goralczyk, Tadeusz
Bartus, Krzysztof
Mazur, Piotr
Dabigatran level monitoring prior to idarucizumab administration in patients requiring emergent cardiac surgery
title Dabigatran level monitoring prior to idarucizumab administration in patients requiring emergent cardiac surgery
title_full Dabigatran level monitoring prior to idarucizumab administration in patients requiring emergent cardiac surgery
title_fullStr Dabigatran level monitoring prior to idarucizumab administration in patients requiring emergent cardiac surgery
title_full_unstemmed Dabigatran level monitoring prior to idarucizumab administration in patients requiring emergent cardiac surgery
title_short Dabigatran level monitoring prior to idarucizumab administration in patients requiring emergent cardiac surgery
title_sort dabigatran level monitoring prior to idarucizumab administration in patients requiring emergent cardiac surgery
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756273/
https://www.ncbi.nlm.nih.gov/pubmed/29222699
http://dx.doi.org/10.1007/s11239-017-1587-9
work_keys_str_mv AT litwinowiczradoslaw dabigatranlevelmonitoringpriortoidarucizumabadministrationinpatientsrequiringemergentcardiacsurgery
AT konstantykalandykjanusz dabigatranlevelmonitoringpriortoidarucizumabadministrationinpatientsrequiringemergentcardiacsurgery
AT goralczyktadeusz dabigatranlevelmonitoringpriortoidarucizumabadministrationinpatientsrequiringemergentcardiacsurgery
AT bartuskrzysztof dabigatranlevelmonitoringpriortoidarucizumabadministrationinpatientsrequiringemergentcardiacsurgery
AT mazurpiotr dabigatranlevelmonitoringpriortoidarucizumabadministrationinpatientsrequiringemergentcardiacsurgery